NCT00800150: Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment |
|
|
| Terminated | 1 | 6 | US | fludarabine phosphate, melphalan, nonmyeloablative allogeneic hematopoietic stem cell transplantation, intensity-modulated radiation therapy, tomotherapy, total marrow irradiation, total nodal irradiation | City of Hope Medical Center, National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms | 10/10 | 10/10 | | |
| Completed | 1 | 20 | US | Decitabine plus Fludarabine and Busulfan | Hackensack Meridian Health | Acute Myeloid Leukemia, Myelodysplastic Syndrome | 12/13 | 12/13 | | |
